Qube Research & Technologies Ltd - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$2
-100.0%
1
-100.0%
0.00%
Q3 2022$43,000
-44.2%
31,434
-10.9%
0.00%
-100.0%
Q2 2022$77,000
-33.0%
35,293
+203.4%
0.00%
-50.0%
Q2 2020$115,00011,6340.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Skylands Capital, LLC 815,869$3,141,0000.46%
Sargent Investment Group, LLC 499,010$1,921,0000.36%
Anson Funds Management LP 74,440$287,0000.33%
One68 Global Capital, LLC 39,241$151,0000.33%
Granahan Investment Management 678,618$2,613,0000.12%
Winning Points Advisors, LLC 30,000$115,0000.07%
Avenir Corp 150,600$580,0000.06%
HighMark Wealth Management LLC 10,000$38,0000.04%
Wealthcare Advisory Partners LLC 62,279$240,0000.03%
GSA CAPITAL PARTNERS LLP 64,970$250,0000.03%
View complete list of CYTOSORBENTS CORP shareholders